ANGELETTI, Gabriella
 Distribuzione geografica
Continente #
NA - Nord America 3.959
EU - Europa 2.817
AS - Asia 2.412
SA - Sud America 421
Continente sconosciuto - Info sul continente non disponibili 178
AF - Africa 62
OC - Oceania 4
Totale 9.853
Nazione #
US - Stati Uniti d'America 3.871
SG - Singapore 1.065
UA - Ucraina 654
IE - Irlanda 509
RU - Federazione Russa 385
CN - Cina 357
BR - Brasile 305
HK - Hong Kong 288
VN - Vietnam 279
IT - Italia 245
DE - Germania 236
SE - Svezia 229
FI - Finlandia 180
FR - Francia 177
KR - Corea 95
GB - Regno Unito 80
IN - India 55
BD - Bangladesh 47
TR - Turchia 45
CA - Canada 39
AR - Argentina 30
IQ - Iraq 29
MX - Messico 25
UZ - Uzbekistan 22
AT - Austria 21
EC - Ecuador 20
PK - Pakistan 20
CH - Svizzera 19
CO - Colombia 19
VE - Venezuela 19
CZ - Repubblica Ceca 18
ID - Indonesia 18
SA - Arabia Saudita 18
PL - Polonia 16
JP - Giappone 15
BE - Belgio 13
ZA - Sudafrica 12
NL - Olanda 11
CL - Cile 10
ES - Italia 10
MA - Marocco 10
MY - Malesia 9
AE - Emirati Arabi Uniti 8
JM - Giamaica 8
PH - Filippine 8
TN - Tunisia 7
KE - Kenya 6
DZ - Algeria 5
EG - Egitto 5
ET - Etiopia 5
LB - Libano 5
PE - Perù 5
PY - Paraguay 5
AL - Albania 4
CR - Costa Rica 4
JO - Giordania 4
AZ - Azerbaigian 3
BH - Bahrain 3
BO - Bolivia 3
LT - Lituania 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PA - Panama 3
RO - Romania 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
HR - Croazia 2
IL - Israele 2
LY - Libia 2
MN - Mongolia 2
PS - Palestinian Territory 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BN - Brunei Darussalam 1
GF - Guiana Francese 1
GR - Grecia 1
HN - Honduras 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
MU - Mauritius 1
MZ - Mozambico 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
QA - Qatar 1
RS - Serbia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 9.680
Città #
Singapore 695
Dublin 508
Chandler 504
Jacksonville 343
San Jose 305
Hong Kong 288
San Mateo 283
Ashburn 250
Boardman 172
Dong Ket 171
Santa Clara 166
Medford 121
Moscow 121
Princeton 121
Lauterbourg 104
Seoul 95
Wilmington 88
Ann Arbor 79
Beijing 78
Andover 77
Munich 69
New York 54
Los Angeles 49
The Dalles 43
Lawrence 37
Piscataway 35
Ho Chi Minh City 32
Hanoi 31
Helsinki 31
Altamura 30
Dallas 29
Des Moines 28
Norwalk 27
Perugia 27
Turku 27
Saint Petersburg 26
Izmir 25
São Paulo 24
Phoenix 22
Orem 21
Brooklyn 19
Woodbridge 17
Chicago 15
Tashkent 15
Atlanta 14
Tokyo 14
Brussels 13
Chennai 13
Auburn Hills 12
Baghdad 12
Denver 12
Frankfurt am Main 12
Mexico City 11
Montreal 11
Rome 11
San Francisco 11
Brno 10
Columbus 10
Falls Church 10
London 10
Rio de Janeiro 10
Toronto 10
Ankara 9
Milan 9
Belo Horizonte 8
Boston 8
Jeddah 8
Warsaw 8
Caracas 7
Fremont 7
Guayaquil 7
Johannesburg 7
Nuremberg 7
Poplar 7
Salvador 7
Shanghai 7
Stockholm 7
Amsterdam 6
Curitiba 6
Da Nang 6
Erbil 6
Falkenstein 6
Florence 6
Foligno 6
Goiânia 6
Lahore 6
Lausanne 6
Mumbai 6
Quito 6
Riyadh 6
Santiago 6
Addis Ababa 5
Bologna 5
Buffalo 5
Casablanca 5
Charlotte 5
Guangzhou 5
Kingston 5
Medellín 5
Nairobi 5
Totale 5.750
Nome #
Administration of Recombinant Human GH on Alternate Days is sufficient to increase whole Body Protein Synthesis and Lipolysis in GH Deficient Adults 292
Microincapsulamento di cellule del Sertoli testicolari in microsfere di alginato di bario 157
Aspetti clinici dei tumori neuroendocrini 146
[Adrenocortical function, carbohydrate metabolism and electrolyte excretion after a month of corticosteroid therapy of bronchial asthma]. 131
Typical Carcinoids of the Lung: Multicentric Forms, Lymph-node Metastases and Long-term Survival in 83 Patients 130
A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults 128
A METHOD FOR THE LARGE-SCALE, HIGH YIELD ISOLATION AND PURIFICATION OF SERTOLI CELLS FROM TESTICLES OF IMPUBERAL PIGS 125
Adrenergic activity and glycometabolic compensation in patients with diabetes mellitus]. 124
Neuroendocrine prevalence in thymic tumors. 122
Thymic Neuroendocrine Carcinoma (Carcinoid) in multiple endocrine neoplasia type 1 Syndrome: the Italian series 122
Tumori neuroendocrini toracici ben differenziati: la corretta gestione clinica 120
[Hypokalemic myopathy in arterial hypertension]. 119
La caratterizzazione biologica dei NET: ruolo diagnostico e prognostico dei marcatori neuroendocrini 117
Analoghi della somatostatina nei tumori neuroendocrini gastro-entero-pancreatici e toracici 116
Well differentiated thoracic neuroendocrine tumors: clinical management and therapy 113
CELLULE DEL SERTOLI TESTICOLARI COME SUPPORTO AI TRAPIANTI DI INSULE PANCREATICHE PER LA TERAPIA DEL DIABETE MELLITO DI TIPO 1 112
Tumori Neuroendocrini del Polmone, aspetti medici 111
Prevalence of the neuroendocrine phenotype in thymus neoplasms. 110
Analoghi della somatostatina nei tumori neuroendocrini gastro-entero-pancreatici e toracici 109
efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study 107
18F-deoxy-D-glucose positron emission tomography (FDG_PET) increases the detection rate of recurrent or residual medullary thyroid cancer 107
Biochemical markers of bone turnover and calcium dietary intake evaluation in HIV-infected patients 103
[The amenorrhea-galactorrhea syndrome. Clinical and therapeutic aspects of 5 treated cases]. 100
EFFICACY AND SAFETY OF HIGH DOSES OF LONG-ACTING SOMATOSTATIN ANALOGUES FOR TREATMENT OF WELL DIFFERENTIATED FUNCTIONING NEUROENDOCRINE TUMORS 99
la tiroide:fisiologia degli ormoni tiroidei 99
Absence of circulating adrenal autoantibodies in adult-onset X-linked adrenoleukodystrophy 98
Efficacy and safety of high dose OCTREOTIDE LAR treatment in patients with progressive well differentiated neuroendocrine tumors 96
Prevalenza del fenotipo neuroendocrino nelle neoplasie del timo 95
Evaluation of accuracy of circulating CgA and NSE in the pre- and post-operative phase in bronchial carcinoids 95
EFFETTO DELLA IPERPROLATTINEMIA SUI RECETTORI ERITROCITARI PER L’INSULINA 92
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group. 91
X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients. 90
Effect of methyl-p-tyrosine administration on gonadotropin and prolactin release in normal-cycling, postmenopausal and hyperprolactinemic women. 89
Absence of circulating adrenal autoantibodies in adult-onset X-linked adrenoleukodystrophy 89
[Changes in the neuroendocrine control of somatotropin secretion in acromegaly]. 88
Efficacy and safety of 48 weeks of treatment with octreotide LAR in newly diagnosed acromegalic patients with macroadenomas: an open-labed, multicenter, non-comparative study. 87
Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. 87
GH-deficit in the developing age: critical analysis of the diagnostic tests 87
[Clinical, diagnostic and therapeutic aspects of hyperprolactinemic states]. 87
FDG-PET, I Metaiodobenylguanidine and 111 in DPTA-Octreotide: scintigraphy for detection of recurrent / residual medullary thyroid cancer 86
Inquadramento dei tumori neuroendocrini 86
Fluid and electrolyte balance after major thoracic surgery by bioimpedance and endocrine evaluation 86
SERTOLI’S CELL (SC)-INDUCED REVERSAL OF ADULT RAT PANCREATIC ISLET b-CELLS (I) INTO FOETAL STATUS : IN VITRO AND IN VIVO IMPLICATIONS FOR I TX FOR THE THERAPY OF DIABETES MELLITUS (DM). 86
The biological characterization of neuroendocrine tumors: the role of neuroendocrine markers. 85
Thymic Neuroendocrine carcinoma (Carcinoid) in MEN1 Syndrome: Characterization of the Three Italian Cases- MEN 2002 84
Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses. 84
Stimulation of pancreatic islet beta-cell mitogeneticity by co-cultured prepuberal rat Sertoli's cells. 83
METHOD FOR SEPARATION, MORPHOLOGICAL AND FUNCTIONAL CHARACTERIZATION OF SERTOLI’S CELLS FROM THE PREPUBERTAL TESTIS : A POTENTIAL NURSING CELL SYSTEM FOR PANCREATIC ISLETS. 83
Tumori endocrini del polmone e paragangliomi - , Convegno I tumori neuroendocrini 81
L'accrescimento staturale: Fisiologia e patologia correlate. 81
“Preliminary study of tumor size response to low and high doses cabergolina therapy in clinically non-functioning macroadenomas with different D2 receptor expression detected with 123-I-IBZM pituitary scintigraphy” 81
Transdifferentiation of human adult pulp dental in neural cells, promoted by pig prepuberal Sertoli cells. 80
[Gynecomastia caused by an estrogen-secreting adrenal neoplasm]. 80
Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study. 79
[Precocious pseudopuberty caused by a Leydig cell neoplasm]. 78
RNA expression bcl-w, a new related protein Bcl-2 family, and caspase-3 in isolated sertoli cells from pre-pubertal rat testes 77
Neuroendocrine prevalence in Thymic Tumors 77
Deficit di GH nell’età evolutiva : analisi critica dei test diagnostici 77
LA TERAPIA DEI PROLATTINOMI IN TEMPO DI SPENDING REVIEW. BROMOCRIPTINA vs CABERGOLINA: ANALISI COSTO-EFFICACIA 77
Results from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study. 77
MALATTIE DELL' IPOTALAMO E DELL' IPOFISI: NEUROENDOCRINOLOGIA 76
La fisiopatologia del timo 76
Counterregulatory hormones during moderate, insulin-induced, blood glucose decrements in man. 75
Encapsulation, in vitro characterization and in vivo biocompatibility of Sertoli cells in alginate-based microcapsules. 75
Continuous subcutaneous insulin infusion treatment in insulin-dependent diabetic patients: a comparison with conventional optimized treatment in a long-term study 74
Effects of long-term optimization and short-term deterioration of glycemic control on glucose counterregulation in type I diabetes mellitus 74
macro-prolactinomas:which the therapeutic space of dopamine-agonists? 74
Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors. 73
neuroendocrine markers and clinical outcome in 100 well differenziated (carcinoid) and 52 poorly differentiated lung neuroendocrine tumours 73
Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer. 73
Octretide LAR in patients with newly diagnosed acromegaly 71
Epidemiologia dei tumori neuroendorini non gastroenteropancreatici 71
Precocious puberty and neurofibromatosis of von Recklinghausen. A clinical report. 71
Efficacy and safety of high doses of long-acting somatostain analogues for treatment of well differentiated secreting neuroendocrine tumors 71
Disappearance of obstructive sleep apnea syndrome(OSAS)in acromegalic man aafter octreotide 70
Sertoli cell-induced reversal of adult rat pancreatic islet beta-cells into fetal-like status: potential implications for islet transplantation in type I diabetes mellitus 70
Malattie dell'ipotalamo e dell'ipofisi:malattie della neuroipofisi 69
[Familial neuro-hormonal diabetes insipidus. Study of 3 clinical cases]. 69
Mitosi beta-cellulari pancreatiche indotte da cellule del Sertoli (SC) di ratto: potenziali applicatori ai TX insulari per la terapia del diabete mellito insulino-dipendente (IDDM). 68
Fundus abnormalities in Cushing's disease: a preliminary report. 68
FDG-PET 123 I METAIODOBENZYLGUANIDINE and 111 IN-DTPA-OCTREOTIDE scintigrafy for detection of recurrent/residual medulary thyroid cancer 68
The adrenergic contribution to glucose counterregulation in type I diabetes mellitus. Dependency on A-cell function and mediation through beta 2-adrenergic receptors 67
Sertoli cell-induced adult rat islet ß-cell mitogenesis: causative pathways. 67
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: a multicenter study. 66
Variation induced by a three-days application of the artificial beta-cell on glucagon, growth hormone and catecholamine secretion, glycosylated hemoglobin, and erythrocyte 2,3-diphosphoglycerate concentration. 66
CD 44 expression as a major prognostic factor in lung neuroendocrine tumors 66
Le basi psiconeuroendocrine della sessualità maschile 65
eziopatogenesi ormonale dell'impotenza 64
[Interstitial deletion of the chromosome 13:46,XX, of 13(q12-q21): description of a case]. 64
Glucagon and carbohydrate disorder in a totally pancreatectomized man (a study with the aid of an artificial endocrine pancreas). 64
EXPRESSION OF FAS-L AND FAS-R mRNAs IN ISOLATED SERTOLI CELLS OF PRE-PUBERTAL RAT TESTES. 63
Glucose intolerance in uremia (A- and B-cell function during conservative and dialytic management. 63
[Empty sella syndrome in a patient with somatic signs of acromegaly]. 63
The metabolic complication of acromegaly 62
Lack of glucagon response in glucose counter-regulation in type 1 (insulin-dependent) diabetics: absence of recovery after prolonged optimal insulin therapy. 62
Artificial beta-cell application in two cases of insulinoma: a different pattern in beta-cell adenoma and carcinoma. 62
Expression of phospholipid-hyperoxide glutathione peroxidase (GPX4) mRNA in isolated Sertoli cells of prepuberal norma rat testis 61
Predictors of morbidity and mortality in acromegaly, an Italian survey. 61
MALATTIE DELL' IPOTALAMO E DELL'IPOFISI: MALATTIE DELL'IPOTALAMO E DELL'IPOFISI ANTERIORE 60
Papillary thyroid carcinoma in a MEN 1 patient.” 60
Totale 8.813
Categoria #
all - tutte 44.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.631


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022697 0 0 26 33 19 7 7 335 8 17 103 142
2022/20231.554 130 156 23 123 137 175 0 79 651 1 62 17
2023/2024588 37 68 35 12 8 8 127 10 95 7 86 95
2024/20251.359 28 168 37 63 183 74 31 107 278 72 206 112
2025/20262.887 219 208 133 378 349 254 452 136 438 230 65 25
2026/2027369 163 146 60 0 0 0 0 0 0 0 0 0
Totale 9.853